Coldrif row: 14 MP kids given banned cough syrup fighting for life in Maharashtra hospitals
In a shocking medical crisis, 14 children from Madhya Pradesh are battling for their lives in hospitals across Maharashtra after consuming a banned cough syrup called Coldrif. The children were reportedly given the syrup despite it being prohibited due to its harmful effects. Following its use, many of them developed severe health complications, including breathing difficulties and organ-related issues. Doctors are working tirelessly to stabilize their condition, with several requiring intensive care support. The alarming incident has sparked widespread concern over the circulation of banned drugs and negligence in their distribution. Health authorities have launched an urgent investigation to identify how the syrup reached these children and why safety protocols were ignored. The tragedy has reignited debates on strict drug regulation, accountability of local health suppliers, and urgent reforms needed to prevent such incidents. Families remain devastated, anxiously waiting for their children’s recovery.
The Key points
- Fourteen children from Madhya Pradesh fell seriously ill.
- They consumed the banned cough syrup Coldrif.
- Victims are currently admitted to Maharashtra hospitals.
- Several children are in intensive care units.
- Syrup linked to severe respiratory and organ complications.
- The drug remains banned due to harmful side effects.
- Investigation launched into drug supply and distribution.
- Authorities tracking negligence behind the syrup’s circulation.
- Families left distressed, awaiting medical updates.
- Incident raises demand for stronger drug safety regulations.
Disclaimer: This preview includes title, image, and description automatically sourced from the original website (timesofindia.indiatimes.com) using publicly available metadata / OG tags. All rights, including copyright and content ownership, remain with the original publisher. If you are the content owner and wish to request removal, please contact us from your official email to no_reply@newspaperhunt.com.
